TL16: Improving Communications Between FDA, Sponsor and Advisory Panel
*Gary Lynn Kamer, FDA/CDRH/OSB/DBS 


The purpose of this session is to describe and discuss the general and specific tools for improved communications during the FDA submission process for new medical devices. The use of pre-meetings, appropriate submission content, and meaningful dialogue with the Advisory Panel will be discussed. Examples of poor and good communications will be given.